FDA approves expanded use of breast cancer drug FDA tentatively approves bone cancer generic FDA approves labeling update for HIV drug URAC gears up for Best Practices Awards AmerisourceBergen sees earnings surge across the board Bayer to halt phase 2 trial of hemophilia treatment Acorda appoints EVP commercial development BioScrip to acquire Critical Homecare Solutions FDA approves Ampyra Teva receives tentative approval for breast cancer drug First Previous 213 214 215 216 217 Next Last
